Press-release for stocks for snynf

Prices are updated after-hours

Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : Snynf crawled time : 05:00

save search

Biopharma Layoff Tracker 2024: Tessera, BenevolentAI, Pfizer and More Cut Staff
Published: 2024-04-24 (Crawled : 05:00) - biospace.com/
RLYB | News | $1.615 -7.18% 190K

|

| 0.0% | O: -5.26% H: 0.0% C: 0.0%
JNJ | News | $148.515 -0.7% 4.3M

|

Health Technology

| 0.0% | O: -1.02% H: 0.0% C: 0.0%
VXRT | News | $0.7208 -3.3% 770K

|

Health Technology

| 0.0% | O: -4.49% H: 0.0% C: 0.0%
SNY | News | $46.765 -1.94% 950K

|

Health Technology

| 0.0% | O: 0.82% H: 0.0% C: 0.0%
PTCT | News S | $25.24 -0.67% 180K

|

Health Technology

| 0.0% | O: -0.29% H: 0.0% C: 0.0%
NKTR | News | $1.4 -1.41% 410K

|

Health Technology

| 0.0% | O: 1.81% H: 0.0% C: 0.0%
MOR | News | $18.06 0.11% 96K

|

Health Technology

| 0.0% | O: 0.06% H: 0.0% C: 0.0%
GLPG | News | $29.08 -1.26% 67K

|

Health Technology

| 0.0% | O: -0.03% H: 0.0% C: 0.0%
AMRN | News | $0.8733 -1.13% 490K

|

Health Technology

| 0.0% | O: 0.91% H: 0.0% C: 0.0%
GOOGL | News S | $158.88 0.39% 13M

|

Technology Services

| 0.0% | O: 0.27% H: 0.0% C: 0.0%
GOOG | News 4 | $160.7 0.49% 11M

|

Technology Services

| 0.0% | O: 0.38% H: 0.0% C: 0.0%
OCX | News | $2.415 -1.63% 27K

|

Health Technology

| 0.0% | O: -3.25% H: 0.0% C: 0.0%
biopharma

Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
Published: 2024-04-23 (Crawled : 05:00) - globenewswire.com
SNY | News | $46.765 -1.94% 950K

|

Health Technology

| 1.7% | O: 1.7% H: 0.0% C: 0.0%
study

23andMe, Innate Pharma Tap Antibodies to Target NK Cells for Cancer
Published: 2024-04-22 (Crawled : 05:00) - biospace.com/
SNY | News | $46.765 -1.94% 950K

|

Health Technology

| 2.56% | O: 0.85% H: 0.0% C: 0.0%
pharma cancer for

Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis
Published: 2024-04-17 (Crawled : 05:00) - globenewswire.com
SNYNF | News | $94.25 480

|

Health Technology

| 2.32% | O: 0.12% H: 0.51% C: 0.51%
SNY | News | $46.765 -1.94% 950K

|

Health Technology

| 2.59% | O: 1.05% H: 0.0% C: 0.0%
sclerosis for potential

Listen Up: Emerging Vocal Biomarker Could Aid ALS Drug Development
Published: 2024-04-15 (Crawled : 05:00) - biospace.com/
SNYNF | News | $94.25 480

|

Health Technology

| 1.45% | O: -0.53% H: 0.61% C: 0.61%
SNY | News | $46.765 -1.94% 950K

|

Health Technology

| 2.36% | O: 1.95% H: 0.0% C: 0.0%
drug als biomarker

Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Endometrial Cancer with Priority Review Status
Published: 2024-04-02 (Crawled : 05:00) - prnewswire.com
LLY | News | $735.1 -1.42% 1.2M

|

Health Technology

| -4.85% | O: -2.79% H: 1.32% C: 1.18%
SNY | News | $46.765 -1.94% 950K

|

Health Technology

| -3.5% | O: -1.14% H: 0.02% C: -1.06%
review cancer treatment advanced china

HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Endometrial Cancer with Priority Review Status
Published: 2024-04-02 (Crawled : 05:00) - globenewswire.com
LLY | News | $735.1 -1.42% 1.2M

|

Health Technology

| -4.85% | O: -2.79% H: 1.32% C: 1.18%
SNY | News | $46.765 -1.94% 950K

|

Health Technology

| -3.5% | O: -1.14% H: 0.02% C: -1.06%
HCM | $18.34 0.49% 38K

|

Health Technology

| 9.31% | O: 0.21% H: 1.49% C: -0.06%
treatment advanced china

Global Artemisinin Market Report 2024, Featuring Profiles of Top Players Including Sanofi, Artemis, KPC Pharmaceuticals, Guilin Pharmaceutical, KERUI, Phytomedics, AIFLINC, Alchem and Sanmark
Published: 2024-03-08 (Crawled : 05:00) - prnewswire.com
SNY | News | $46.765 -1.94% 950K

|

Health Technology

| -2.16% | O: -0.08% H: 0.0% C: 0.0%
report global market

2024 Tech M&A Regulation Thematic Research Report | Now Available
Published: 2024-03-08 (Crawled : 05:00) - prnewswire.com
SNY | News | $46.765 -1.94% 950K

|

Health Technology

| -2.16% | O: -0.08% H: 0.0% C: 0.0%
report research

TL1A Inhibitors Could Usher in New Era for IBD Treatment
Published: 2024-02-26 (Crawled : 05:00) - biospace.com/
SNYNF | News | $94.25 480

|

Health Technology

| -3.08% | O: -0.82% H: 0.0% C: 0.0%
SNY | News | $46.765 -1.94% 950K

|

Health Technology

| -2.73% | O: 0.89% H: 0.0% C: 0.0%
treatment

Generic Drugs Market to grow by USD 176.25 billion from 2022 to 2027, North America is estimated to contribute 37% to the growth - Technavio
Published: 2024-02-08 (Crawled : 05:00) - prnewswire.com
ENDPQ | News | $0.0007 -50.0% 1K

|

| 471.43% | O: -14.29% H: 16.67% C: 0.0%
GLAXF | News | $19.54 2.6K

|

Health Technology

| -6.19% | O: 0.82% H: 0.0% C: 0.0%
SNYNF | News | $94.25 480

|

Health Technology

| 0.61% | O: -1.64% H: 0.0% C: 0.0%
VTRS | News A | $11.42 0.53% 1.7M

|

Health Technology

| -3.24% | O: -0.34% H: 0.0% C: -1.2%
NVS | News | $98.1 0.84% 1.3M

|

Health Technology

| -4.45% | O: -1.57% H: 0.26% C: -0.47%
GSK | News | $40.905 -0.81% 890K

|

Health Technology

| -1.86% | O: -0.48% H: 0.16% C: 0.0%
BAX | $40.84 -0.44% 840K

|

Health Technology

| 4.16% | O: -0.96% H: 5.91% C: 3.74%
ABT | News | $106.96 -0.59% 2.6M

|

Health Technology

| -6.02% | O: -1.41% H: 0.0% C: 0.0%
SNY | News | $46.765 -1.94% 950K

|

Health Technology

| -0.19% | O: -2.25% H: 0.0% C: 0.0%
AMGN | News | $274.15 0.22% 900K

|

Health Technology

| -7.55% | O: 0.38% H: 0.34% C: -0.72%
america growth market

Over-The-Counter Drug Market to Grow by USD 58.54 billion from 2022 to 2027, Abbott Laboratories, Achelios Therapeutics Inc., AstraZeneca Plc, Bayer AG, BioGaia AB as Key Market Contributors - 17000+ Technavio Reports
Published: 2024-01-24 (Crawled : 05:00) - prnewswire.com
RBGPF | News | $52.06 4.8K

|

Consumer Non-Durables

| -26.86% | O: -1.75% H: 0.0% C: 0.0%
SNYNF | News | $94.25 480

|

Health Technology

| -8.58% | O: -3.01% H: 0.69% C: -0.75%
AZNCF | News | $140.3 1.5K

|

Health Technology

| 4.0% | O: -0.42% H: 0.0% C: -1.8%
RBGLY | News | $10.59 850K

|

| -23.99% | O: -0.35% H: 0.07% C: -0.14%
NVS | News | $98.1 0.84% 1.3M

|

Health Technology

| -8.23% | O: 0.22% H: 0.43% C: -0.39%
GSK | News | $40.905 -0.81% 890K

|

Health Technology

| 4.99% | O: 0.48% H: 0.66% C: -1.11%
ABT | News | $106.96 -0.59% 2.6M

|

Health Technology

| -6.32% | O: -3.45% H: 0.0% C: 0.0%
SNY | News | $46.765 -1.94% 950K

|

Health Technology

| -6.03% | O: 0.92% H: 0.0% C: 0.0%
AZN | News | $71.26 0.58% 3.8M

|

Health Technology

| 6.14% | O: -0.03% H: 0.29% C: -0.19%
drug astrazeneca key therapeutics market

USD 10.40 billion growth in Vascular Endothelial Market between 2022 and 2027, The strategic alliances and collaborations are notably driving market growth-17,000+ Technavio Research Reports
Published: 2024-01-22 (Crawled : 05:00) - prnewswire.com
SNYNF | News | $94.25 480

|

Health Technology

| -7.16% | O: 1.71% H: 0.0% C: -0.15%
AZNCF | News | $140.3 1.5K

|

Health Technology

| 6.45% | O: 2.63% H: 0.8% C: 0.75%
NVSEF | News | $96.0 52K

|

Health Technology

| -10.28% | O: 1.4% H: 0.0% C: 0.0%
VTRS | News A | $11.42 0.53% 1.7M

|

Health Technology

| -0.35% | O: -0.18% H: 2.37% C: 2.28%
NVS | News | $98.1 0.84% 1.3M

|

Health Technology

| -8.66% | O: 0.12% H: 0.39% C: 0.1%
ABBV | News | $168.21 -0.78% 1.2M

|

Health Technology

| 3.87% | O: 0.57% H: 0.0% C: 0.0%
SNY | News | $46.765 -1.94% 950K

|

Health Technology

| -8.16% | O: -0.21% H: 0.0% C: 0.0%
AZN | News | $71.26 0.58% 3.8M

|

Health Technology

| 6.48% | O: 1.8% H: 0.14% C: -0.89%
AMGN | News | $274.15 0.22% 900K

|

Health Technology

| -11.13% | O: 0.29% H: 1.12% C: 0.47%
research growth market

Osteoarthritis Therapeutics Market to grow by USD 3.96 billion from 2022-2027, North America to account for 32% of market growth - Technavio
Published: 2024-01-17 (Crawled : 05:00) - prnewswire.com
GLAXF | News | $19.54 2.6K

|

Health Technology

| -0.26% | O: -0.56% H: 0.0% C: 0.0%
SNYNF | News | $94.25 480

|

Health Technology

| -9.29% | O: -1.83% H: 0.0% C: 0.0%
VTRS | News A | $11.42 0.53% 1.7M

|

Health Technology

| -3.32% | O: -1.02% H: 0.95% C: -1.46%
NVS | News | $98.1 0.84% 1.3M

|

Health Technology

| -8.2% | O: 0.49% H: 0.18% C: 0.04%
GSK | News | $40.905 -0.81% 890K

|

Health Technology

| 3.41% | O: -0.08% H: 0.1% C: -0.18%
ABT | News | $106.96 -0.59% 2.6M

|

Health Technology

| -5.19% | O: 0.12% H: 0.77% C: 0.27%
SNY | News | $46.765 -1.94% 950K

|

Health Technology

| -8.92% | O: 0.45% H: 0.06% C: -0.5%
ANIK | $26.07 1.09% 11K

|

Health Technology

| 17.49% | O: -1.05% H: 3.55% C: 3.31%
america osteoarthritis therapeutics growth market

Nontuberculous Mycobacterial Infections Market size to grow by USD 4.33 billion from 2023 to 2028, North America to account for 40% of market growth- Technavio
Published: 2024-01-10 (Crawled : 05:00) - prnewswire.com
ALPMY | News | $9.49 480K

|

| -21.2% | O: 1.19% H: 0.2% C: 0.03%
VTRS | News A | $11.42 0.53% 1.7M

|

Health Technology

| -2.07% | O: -0.09% H: 7.77% C: 4.4%
ABT | News | $106.96 -0.59% 2.6M

|

Health Technology

| -4.16% | O: 0.76% H: 0.0% C: 0.0%
SNY | News | $46.765 -1.94% 950K

|

Health Technology

| -9.34% | O: 0.13% H: 0.0% C: 0.0%
america infections market

Enhancing Leadership in Gynecology, Asieris Pharmaceuticals Appoints Sophia Cao to Lead the Newly-Established Women's Health Business Unit, Accelerating Strategic Expansion
Published: 2024-01-09 (Crawled : 05:00) - prnewswire.com
SNY | News | $46.765 -1.94% 950K

|

Health Technology

| -8.67% | O: 0.74% H: 0.0% C: 0.0%
business health pharmaceuticals expansion

United States Blood Glucose Monitoring Devices Market Report 2023-2028: New Products Significantly Impact the Demand for Devices - AI and IoT Advancements Fueling Growth
Published: 2023-12-13 (Crawled : 05:00) - prnewswire.com
SNYNF | News | $94.25 480

|

Health Technology

| 0.52% | O: -0.06% H: 2.36% C: 2.36%
MDT | $80.37 -1.13% 2.6M

|

Health Technology

| 1.51% | O: -0.45% H: 2.76% C: 2.73%
BDX | $233.97 -0.17% 420K

|

Health Technology

| -0.98% | O: -0.09% H: 1.72% C: 1.7%
ABT | News | $106.96 -0.59% 2.6M

|

Health Technology

| 1.07% | O: -0.48% H: 0.0% C: 0.0%
SNY | News | $46.765 -1.94% 950K

|

Health Technology

| -0.74% | O: -0.27% H: 2.28% C: 2.16%
PODD | $167.175 -0.06% 310K

|

Health Technology

| -15.22% | O: -0.28% H: 4.22% C: 4.11%
DXCM | $137.17 2.37% 1.4M

|

Health Technology

| 12.45% | O: -0.02% H: 2.72% C: 2.64%
report iot blood impact growth market

Innovent Announces Inclusion in the China National Reimbursement Drug List of TYVYT® 's Seventh Indication and BYVASDA®'s Eighth Indication
Published: 2023-12-13 (Crawled : 05:00) - prnewswire.com
SNYNF | News | $94.25 480

|

Health Technology

| 0.52% | O: -0.06% H: 2.36% C: 2.36%
LLY | News | $735.1 -1.42% 1.2M

|

Health Technology

| 27.13% | O: 0.32% H: 0.0% C: 0.0%
SNY | News | $46.765 -1.94% 950K

|

Health Technology

| -0.74% | O: -0.27% H: 2.28% C: 2.16%
INCY | $51.76 0.21% 600K

|

Health Technology

| -16.51% | O: 0.95% H: 3.83% C: 2.79%
tyvyt drug china

Precision Medicine Market size to grow by USD 54.07 billion from 2022 to 2027, The growing prevalence of chronic diseases to boost market growth - Technavio
Published: 2023-12-12 (Crawled : 05:00) - prnewswire.com
AZNCF | News | $140.3 1.5K

|

Health Technology

| 12.06% | O: 5.03% H: 0.0% C: -3.82%
NVSEF | News | $96.0 52K

|

Health Technology

| 0.0% | O: 1.56% H: 0.51% C: 0.51%
TMO | News | $576.13 0.27% 1.1M

|

Health Technology

| 15.08% | O: 0.86% H: 0.0% C: 0.0%
NVS | News | $98.1 0.84% 1.3M

|

Health Technology

| 1.62% | O: 0.45% H: 0.75% C: 0.46%
ABBV | News | $168.21 -0.78% 1.2M

|

Health Technology

| 12.4% | O: 0.59% H: 1.23% C: 1.0%
SNY | News | $46.765 -1.94% 950K

|

Health Technology

| -0.31% | O: 0.43% H: 0.0% C: 0.0%
AZN | News | $71.26 0.58% 3.8M

|

Health Technology

| 11.57% | O: 1.54% H: 0.06% C: -0.78%
AMGN | News | $274.15 0.22% 900K

|

Health Technology

| 0.51% | O: 1.83% H: 0.04% C: -1.13%
growing growth market

Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Type 2 Diabetes in Diabetes Care
Published: 2023-11-22 (Crawled : 05:00) - prnewswire.com
SNYNF | News | $94.25 480

|

Health Technology

| 1.31% | O: -0.74% H: 0.71% C: 0.71%
LLY | News | $735.1 -1.42% 1.2M

|

Health Technology

| 23.58% | O: -0.44% H: 0.63% C: -0.05%
SNY | News | $46.765 -1.94% 950K

|

Health Technology

| 1.01% | O: -0.34% H: 0.0% C: 0.0%
ibi362 publication care chinese diabetes results phase 2

← Previous
1
2
3
4
Next →

Gainers vs Losers

58%

42%

Top 10 Gainers

CZOO | $10.52 110.82% 10M

|

CSSE 4 | $0.3181 108.86% 170M

|

Consumer Services

BOF | $1.88 60.68% 98M

|

AMST | $3.1 55.0% 66M

|

Technology Services

LICN | $0.85 51.79% 13M

|

WIMI | $1.03 41.99% 15M

|

Technology Services

SKIL 4 | $8.045 40.89% 230K

|

MULN | News | $3.805 39.38% 11M

|

RILY | $30.01 38.17% 11M

|

MTC | $3.04 35.71% 6.7M

|

Technology Services

Your saved searches

Save your searches and get alerts when important news are released.